# MoonLake Immunotherapeutics: Form 8-K/A, filed May 16, 2022

- Company: [MoonLake Immunotherapeutics](/companies/mltx.md) (CIK 1821586)
- Form: 8-K/A
- Filed: 2022-05-16
- Accepted by EDGAR: May 16, 2022, 16:10 ET
- Period: 2022-04-05
- Accession: 0001213900-22-027102
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1821586/000121390022027102/ea159897-8ka1_moonlake.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1821586/000121390022027102/

## Items reported

- Item 2.01: Completion of an acquisition or disposition
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1821586/000121390022027102/ea159897-8ka1_moonlake.htm

Filed May 16, 2022.
Source: SEC EDGAR, the filing index for accession 0001213900-22-027102. Last ingested by Listed: Nov 4, 2026, 07:34 ET. No prices; not investment advice.
